DEUTSCHE BANK AG\ - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 145 filers reported holding IMMUNOGEN INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$3,571,797
-94.3%
225,066
-93.2%
0.00%
-93.9%
Q2 2023$62,360,198
+427.6%
3,304,727
+7.4%
0.03%
+371.4%
Q1 2023$11,818,921
-21.6%
3,077,844
+1.3%
0.01%
-22.2%
Q4 2022$15,066,297
+4.8%
3,037,560
+1.0%
0.01%0.0%
Q3 2022$14,371,000
+5.4%
3,006,485
-0.8%
0.01%
+12.5%
Q2 2022$13,640,000
-2.7%
3,030,994
+2.9%
0.01%
+14.3%
Q1 2022$14,022,000
+2.6%
2,945,717
+60.0%
0.01%
+16.7%
Q4 2021$13,666,000
+31.3%
1,841,640
+0.3%
0.01%
+20.0%
Q3 2021$10,407,000
-14.6%
1,835,446
-0.7%
0.01%
-16.7%
Q2 2021$12,180,000
-49.8%
1,848,193
-38.3%
0.01%
-53.8%
Q1 2021$24,252,000
+31.8%
2,994,172
+5.0%
0.01%
+18.2%
Q4 2020$18,399,000
+187.3%
2,852,446
+60.3%
0.01%
+175.0%
Q3 2020$6,405,000
+70.4%
1,779,391
+117.7%
0.00%
+33.3%
Q2 2020$3,759,000
-16.2%
817,310
-37.9%
0.00%
-25.0%
Q1 2020$4,487,000
+607.7%
1,315,863
+957.7%
0.00%
Q4 2019$634,000
+18.5%
124,411
-43.9%
0.00%
Q3 2019$535,000
-73.5%
221,958
-76.2%
0.00%
-100.0%
Q2 2019$2,021,000
-68.5%
932,241
-60.6%
0.00%
-75.0%
Q1 2019$6,415,000
+7.6%
2,368,015
+90.6%
0.00%0.0%
Q4 2018$5,962,000
-55.3%
1,242,243
-11.8%
0.00%0.0%
Q3 2018$13,335,000
+119.7%
1,408,337
+125.7%
0.00%
+100.0%
Q2 2018$6,071,000
-40.1%
624,091
-35.2%
0.00%
-60.0%
Q1 2018$10,135,000
+137.0%
963,647
+44.4%
0.01%
+66.7%
Q4 2017$4,277,000
-45.4%
667,504
-34.8%
0.00%
-40.0%
Q3 2017$7,834,000
+13.9%
1,024,165
+5.8%
0.01%0.0%
Q2 2017$6,878,000
+0.7%
967,615
-45.2%
0.01%0.0%
Q1 2017$6,829,000
+73.6%
1,765,021
-8.5%
0.01%
+66.7%
Q4 2016$3,934,000
-6.3%
1,929,353
+23.1%
0.00%0.0%
Q3 2016$4,197,000
-6.8%
1,566,956
+7.2%
0.00%0.0%
Q2 2016$4,502,000
+106.0%
1,462,204
+469.7%
0.00%
+50.0%
Q1 2016$2,185,000
-45.2%
256,668
-12.7%
0.00%
-33.3%
Q4 2015$3,986,000
-24.7%
293,909
-46.7%
0.00%
-25.0%
Q3 2015$5,294,000
-22.1%
551,721
+16.7%
0.00%0.0%
Q2 2015$6,799,000
+47.8%
472,939
-8.1%
0.00%
+33.3%
Q1 2015$4,601,000
+39.5%
514,466
-4.9%
0.00%
+50.0%
Q4 2014$3,299,000
-22.5%
541,021
+34.6%
0.00%
-33.3%
Q3 2014$4,256,000
-39.4%
402,073
-32.2%
0.00%
-40.0%
Q2 2014$7,027,000
+29.7%
593,127
+63.5%
0.01%
+25.0%
Q1 2014$5,416,000
-1.6%
362,827
-3.4%
0.00%0.0%
Q4 2013$5,505,000
-39.4%
375,729
-29.6%
0.00%
-42.9%
Q3 2013$9,083,000533,8060.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders